Study and Analysis of Micafungin for Non-albican Candidemia: Efficacy, Risk Factor and Clinical Manifestation
NCT01317394 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2011-03-17
Summary
This study is a retrospective research in order to compare and analysis the risk factor, clinical manifestation and efficacy of albicans candidemia by pulling medical records. We hope that this retrospective research will let us understand the method of treatment and prevention of albicans candidemia in order to improve the quality of healthcare.
Conditions
- Non-albicans Candidemia
Sponsors & Collaborators
-
Taipei Medical University WanFang Hospital
lead OTHER
Principal Investigators
-
Wen-Sen Lee · Taipei Medical University WanFang Hospital
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-12-31
- Completion
- 2011-02-28
Countries
- Taiwan
Study Locations
More Related Trials
-
The Relationship Between Morphology and Virulent Genes of Candida Albicans and Clinical Aspects, Surveillance of Fungemia
NCT01211041 ·Status: UNKNOWN
-
A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)
NCT00717860 ·Status: COMPLETED ·Phase: PHASE3
-
Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp
NCT02646800 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluate Bioequivalence of Micafungin (50mg/Vial)
NCT05496725 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis
NCT01176058 ·Status: TERMINATED ·Phase: PHASE3
-
Caspofungin for the Treatment of Non-blood Candida Infections (0991-045)
NCT00083343 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis
NCT00666185 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in Neonates
NCT00818584 ·Status: COMPLETED ·Phase: PHASE1
-
Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute Leukemia
NCT02440178 ·Status: COMPLETED ·Phase: PHASE2
-
Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents
NCT01686607 ·Status: COMPLETED
-
Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)
NCT02180165 ·Status: COMPLETED ·Phase: PHASE3
-
Anidulafungin Versus Fluconazole in the Treatment of Candidemia
NCT00058682 ·Status: COMPLETED ·Phase: PHASE3
-
Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation
NCT01135589 ·Status: UNKNOWN ·Phase: PHASE4
-
Fluconazole Versus Micafungin in Neonates With Candidiasis
NCT02145832 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida Meningitis
NCT03421002 ·Status: COMPLETED ·Phase: PHASE2
-
Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis
NCT02646774 ·Status: TERMINATED ·Phase: PHASE4
-
Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients
NCT00304772 ·Status: WITHDRAWN ·Phase: PHASE4
-
Anidulafungin In Treatment Of Candidemia In Asian Subjects
NCT00537329 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis
NCT00665639 ·Status: COMPLETED ·Phase: PHASE3
-
Micafungin Prevention Study for Invasive Fungal Disease in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
NCT01417169 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis
NCT00036179 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects
NCT01122368 ·Status: COMPLETED ·Phase: PHASE2
-
Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases
NCT01344681 ·Status: COMPLETED ·Phase: PHASE2
-
Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE Study
NCT03174457 ·Status: COMPLETED
-
Diflucan Research For Infant Evaluation Of Antifungal Treatment And Prophylaxis Medication
NCT01680458 ·Status: COMPLETED